ZeClinics Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 5
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $2.01M
Latest Deal Amount
  • Investors
  • 1

ZeClinics General Information


Provider of a biotechnology platform intended to develop drugs and pharmaceuticals using zebrafish. The company's experimental platform tracks toxicity data, preserves embryos of marine species, tests and utilizes zebrafish larvae in toxicology screening of drugs and related protein molecules, enabling bio technologists to test toxicity of drugs and recommend dosage with the help of zebrafish screening and nullification.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • Almogàvers Business Factory. Office 205
  • C/Almogavers, 165
  • 08018 Barcelona
  • Spain
+34 933 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ZeClinics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Dec-2016 $2.01M Completed Startup
1. Equity Crowdfunding 31-May-2015 00000 00.000 Completed Startup
To view ZeClinics’s complete valuation and funding history, request access »

ZeClinics Executive Team (4)

Name Title Board Seat Contact Info
Davide D'Amico Ph.D Co-Founder & Chief Executive Officer
Ignasi Sahún Ph.D Co-Founder & Chief Marketing Officer
Javier Terriente Ph.D Co-Founder & Chief Scientific Officer
Simone Calzolari Ph.D Co-Founder & Chief Commercial Officer
To view ZeClinics’s complete executive team members history, request access »

ZeClinics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ZeClinics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
To view ZeClinics’s complete investors history, request access »